Quercetin prevents ethanol-induced iron overload by regulating hepcidin through the BMP6/SMAD4 signaling pathway

Journal of Nutritional Biochemistry

Volumn 25, Issue 6, 2014, Pages 675-682

  Tang, Yuhan ^a   Li, Yanyan ^a   Yu, Haiyan ^a   Gao, Chao ^a   Liu, Liang ^a   Chen, Shaodan ^a   Xing, Mingyou ^a   Yao, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alcoholic liver diseases (ALD); Bone morphogenetic protein 6 (BMP6) SMAD4; Hepcidin; Iron overload; Quercetin

Indexed keywords

ALCOHOL; BONE MORPHOGENETIC PROTEIN 6; CARBONYL IRON; HEPCIDIN; IRON; MESSENGER RNA; QUERCETIN; SMAD4 PROTEIN; ANTIOXIDANT; RECOMBINANT PROTEIN; SMAD4 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIE; CONTROLLED STUDY; DIET; DISEASE EXACERBATION; GENE EXPRESSION; INCUBATION TIME; IRON OVERLOAD; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPPLEMENTATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEPATIC INSUFFICIENCY; HUMAN; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION;

ANIMALS; ANTIOXIDANTS; BONE MORPHOGENETIC PROTEIN 6; CELLS, CULTURED; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ETHANOL; GENE EXPRESSION REGULATION; HEPATIC INSUFFICIENCY; HEPATOCYTES; HEPCIDINS; HUMANS; IRON CARBONYL COMPOUNDS; IRON OVERLOAD; LIVER; MALE; MICE, INBRED C57BL; QUERCETIN; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN;

EID: 84899852890     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.02.009     Document Type: Article

References (50)

1. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
2. Whitfield J.B., Zhu G., Heath A.C., Powell A.L., Martin N.G. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res 2001, 25:1037-1045.
3. Valerio L.J., Parks T., Petersen D.R. Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol Clin Exp Res 1996, 20:1352-1361.
4. Tsukamoto H., Horne W., Kamimura S., Niemela O., Parkkila S., Yla-Herttuala S., et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995, 96:620-630.
5. Harrison-Findik D.D., Schafer D., Klein E., Timchenko N.A., Kulaksiz H., Clemens D., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 2006, 281:22974-22982.
6. Bridle K., Cheung T.K., Murphy T., Walters M., Anderson G., Crawford D.G., et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res 2006, 30:106-112.
7. Harrison-Findik D.D., Klein E., Crist C., Evans J., Timchenko N., Gollan J. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 2007, 46:1979-1985.
8. Harrison-Findik D.D. Role of alcohol in the regulation of iron metabolism. World J Gastroenterol 2007, 13:4925-4930.
9. Andriopoulos B.J., Corradini E., Xia Y., Faasse S.A., Chen S., Grgurevic L., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009, 41:482-487.
10. Gao J., Chen J., De Domenico I., Koeller D.M., Harding C.O., Fleming R.E., et al. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 2010, 115:3374-3381.
11. Wallace D.F., Summerville L., Crampton E.M., Frazer D.M., Anderson G.J., Subramaniam V.N. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009, 50:1992-2000.
12. Fleming R.E. Hepcidin activation during inflammation: make it STAT. Gastroenterology 2007, 132:447-449.
13. Tanno T., Bhanu N.V., Oneal P.A., Goh S.H., Staker P., Lee Y.T., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007, 13:1096-1101.
14. Tanno T., Porayette P., Sripichai O., Noh S.J., Byrnes C., Bhupatiraju A., et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 2009, 114:181-186.
15. Meynard D., Kautz L., Darnaud V., Canonne-Hergaux F., Coppin H., Roth M.P. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009, 41:478-481.
16. Arndt S., Maegdefrau U., Dorn C., Schardt K., Hellerbrand C., Bosserhoff A.K. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 2010, 138:372-382.
17. Kautz L., Meynard D., Monnier A., Darnaud V., Bouvet R., Wang R.H., et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008, 112:1503-1509.
18. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005, 2:399-409.
19. Gerjevic L.N., Liu N., Lu S., Harrison-Findik D.D. Alcohol activates TGF-beta but inhibits BMP receptor-mediated Smad signaling and Smad4 binding to hepcidin promoter in the liver. Int J Hepatol 2012, 2012:459278.
20. Stal P., Johansson I., Ingelman-Sundberg M., Hagen K., Hultcrantz R. Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation. J Hepatol 1996, 25:538-546.
21. Boesch-Saadatmandi C., Loboda A., Wagner A.E., Stachurska A., Jozkowicz A., Dulak J., et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem 2011, 293-299.
22. Zhang Y., Gao Z., Liu J., Xu Z. Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues. Nat Prod Res 2011, 25:1150-1160.
23. Zhang Y., Li H., Zhao Y., Gao Z. Dietary supplementation of baicalin and quercetin attenuates iron overload induced mouse liver injury. Eur J Pharmacol 2006, 535:263-269.
24. Vanhees K., Godschalk R.W., Sanders A., van Waalwijk V.D.S., van Schooten F.J. Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood. Toxicology 2011, 290:350-358.
25. Cao W., Collins Q.F., Becker T.C., Robidoux J., Lupo E.G., Xiong Y., et al. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem 2005, 280:42731-42737.
26. Weinmann A.S., Bartley S.M., Zhang T., Zhang M.Q., Farnham P.J. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 2001, 21:6820-6832.
27. Ohtake T., Saito H., Hosoki Y., Inoue M., Miyoshi S., Suzuki Y., et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res 2007, 31:S2-S8.
28. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146.
29. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev 2005, 19:2783-2810.
30. Piek E., Heldin C.H., Ten D.P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. Faseb J 1999, 13:2105-2124.
31. Heldin C.H., Miyazono K., Ten D.P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
32. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004, 36:77-82.
33. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006, 38:531-539.
34. Nath B., Levin I., Csak T., Petrasek J., Mueller C., Kodys K., et al. Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 2011, 53:1526-1537.
35. Chaston T.B., Matak P., Pourvali K., Srai S.K., McKie A.T., Sharp P.A. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol 2011, 300:C888-C895.
36. Yan J.D., Yang S., Zhang J., Zhu T.H. BMP6 reverses TGF-beta1-induced changes in HK-2 cells: implications for the treatment of renal fibrosis. Acta Pharmacol Sin 2009, 30:994-1000.
37. Du J., Zhu Y., Chen X., Fei Z., Yang S., Yuan W., et al. Protective effect of bone morphogenetic protein-6 on neurons from H2O2 injury. Brain Res 2007, 1163:10-20.
38. Yang L., Inokuchi S., Roh Y.S., Song J., Loomba R., Park E.J., et al. Transforming growth factor-beta signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 2013, 144:1042-1054.
39. Silvestri Laura Inhibiting the hepcidin inhibitor for treatment of iron overload. Blood 2013, 121:1068-1069.
40. Daba A., Gkouvatsos K., Sebastiani G., Pantopoulos K. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing. J Mol Med (Berl) 2013, 91:95-102.
41. Fuqua B.K., Vulpe C.D., Anderson G.J. Intestinal iron absorption. J Trace Elem Med Biol 2012, 26:115-119.
42. Ambadath V., Venu R.G., Madambath I. Comparative study of the efficacy of ascorbic acid, quercetin, and thiamine for reversing ethanol-induced toxicity. J Med Food 2010, 13:1485-1489.
43. Tang Y., Gao C., Xing M., Li Y., Zhu L., Wang D., et al. Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage. Food Chem Toxicol 2012, 50:1194-1200.
44. Baccan M.M., Chiarelli-Neto O., Pereira R.M., Esposito B.P. Quercetin as a shuttle for labile iron. J Inorg Biochem 2012, 107:34-39.
45. Wang C., Hu F., Guo S., Mi D., Shen W., Zhang J., et al. BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells. J Cancer Res Clin Oncol 2011, 137:985-995.
46. Yao P., Nussler A., Liu L., Hao L., Song F., Schirmeier A., et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 2007, 47:253-261.
47. Yao P., Hao L., Nussler N., Lehmann A., Song F., Zhao J., et al. The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. Am J Physiol Gastrointest Liver Physiol 2009, 296:G1318-G1323.
48. Triantafyllou A., Mylonis I., Simos G., Bonanou S., Tsakalof A. Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 2008, 44:657-670.
49. Hasebe Y., Egawa K., Yamazaki Y., Kunimoto S., Hirai Y., Ida Y., et al. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol Pharm Bull 2003, 26:1379-1383.
50. Sarkar A., Angeline M.S., Anand K., Ambasta R.K., Kumar P. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model. Brain Res 2012, 1481:59-70.